Evidence map›Paper›PMID 38088346›Full record

ArticleDisability and rehabilitation2024

Improving telehealth for persons with multiple sclerosis - a cross-sectional study from the Australian MS longitudinal study.

Y C Learmonth, B Galna, L L Laslett, I van der Mei, C H Marck

Open access · bronzeAbstract read
In one paragraph

Article in Disability and rehabilitation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Y C LearmonthSchool of Allied Health (Exercise Science), Murdoch University, Western Australia, Australia.
B GalnaSchool of Allied Health (Exercise Science), Murdoch University, Western Australia, Australia.
L L LaslettMenzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
I van der MeiMenzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
C H MarckDisability and Health Unit, the Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
Murdoch University · AUUniversity of Tasmania · AUThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe COVID-19 pandemic impacted healthcare delivery, especially for people with chronic disease. We investigated telehealth use by persons with multiple sclerosis (MS) during the COVID-19 pandemic and their suggestions to improve their telehealth experience.

methodsFrom persons with MS, we collected data on demographic, disease-related and social determinants of health, telehealth use during the COVID-19 pandemic, satisfaction with telehealth, and suggestions to improve telehealth. We conducted univariate log-binomial regression to establish factors associated with telehealth use versus no use, summarised experiences and suggestions for improvement with frequency tables, and conducted thematic analysis on free-text suggestions for improvement.

resultsOf 1,485 participants, 69.8% used telehealth during the first phase of the COVID-19 pandemic. Only small differences were observed for demographic, disease and social health determinants between telehealth users and non-users. Most participants who used telehealth had good or very good experiences (new providers:74.3%; existing providers:78.6%). The most common suggestion for improving telehealth experience was "guidance on preparing for telehealth sessions." Participants also wanted expansion in telehealth availability and utility.

conclusionPersons with MS in Australia commonly used telehealth during the COVID-19 pandemic and were generally satisfied with their experiences. Implementing the suggested improvements will help optimise telehealth for persons with MS. REGISTRATION: N/A.

Indexed as

COVID-19Multiple SclerosisSARS-CoV-2TelemedicineAdultAgedAustraliaCross-Sectional StudiesFemaleHumansLongitudinal StudiesMaleMiddle AgedPatient SatisfactionconsumerCOVID-19Multiple sclerosistelehealth

Identifiers

PMID38088346
PMCPMC11441396
OpenAlexW4389673194

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.